Evinacumab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Evinacumab. Educational only — not medical advice.
Labeled uses
EVKEEZA is indicated as an adjunct to diet and exercise and other low-density lipoprotein-cholesterol (LDL-C) lowering therapies to reduce LDL-C in adults and pediatric patients, aged 1 year and older, with homozygous familial hypercholesterolemia (HoFH).
Source: FDA labeling via NIH DailyMed (set 73412138…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.